Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology (Q36648476)

From Wikidata

Jump to navigation Jump to search

scientific article published on 8 November 2006

Language	Label	Description	Also known as
English	Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology	scientific article published on 8 November 2006

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology (English)

1 reference

Europe PubMed Central

15 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

S Young

12

0 references

object named as

K Matthews

6

0 references

object named as

K Fone

2

0 references

author name string

D J Nutt

1

1 reference

Europe PubMed Central

15 August 2017

P Asherson

3

1 reference

Europe PubMed Central

15 August 2017

D Bramble

4

1 reference

Europe PubMed Central

15 August 2017

P Hill

5

1 reference

Europe PubMed Central

15 August 2017

K A Morris

7

1 reference

Europe PubMed Central

15 August 2017

P Santosh

8

1 reference

Europe PubMed Central

15 August 2017

E Sonuga-Barke

9

1 reference

Europe PubMed Central

15 August 2017

E Taylor

10

1 reference

Europe PubMed Central

15 August 2017

M Weiss

11

1 reference

Europe PubMed Central

15 August 2017

British Association for Psychopharmacology

13

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

8 November 2006

1 reference

Europe PubMed Central

15 August 2017

Journal of Psychopharmacology

1 reference

Europe PubMed Central

15 August 2017

21

1 reference

Europe PubMed Central

15 August 2017

10-41

1 reference

Europe PubMed Central

15 August 2017

1

1 reference

Europe PubMed Central

15 August 2017

Training raters to assess adult ADHD: reliability of ratings

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Clinical assessment and treatment of attention deficit hyperactivity disorder in adults

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Unravelling the complexity of attention-deficit hyperactivity disorder: a behavioural genomic approach

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The alpha-2A-adrenoceptor agonist, guanfacine, increases regional cerebral blood flow in dorsolateral prefrontal cortex of monkeys performing a spatial working memory task.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Childhood conduct problems, hyperactivity-impulsivity, and inattention as predictors of adult criminal activity

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Frontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research report

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Normalized functioning in youths with persistent attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Attention-deficit/hyperactivity disorder: a selective overview

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Sources of covariation among the child-externalizing disorders: informant effects and the shared environment

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Enduring behavioral effects of early exposure to methylphenidate in rats

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Effects of a few food diet in attention deficit disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Characterizing cognition in ADHD: beyond executive dysfunction

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Whither causal models in the neuroscience of ADHD?

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

A prepubertal and early adolescent bipolar disorder-I phenotype: review of phenomenology and longitudinal course

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Understanding the covariation among childhood externalizing symptoms: genetic and environmental influences on conduct disorder, attention deficit hyperactivity disorder, and oppositional defiant disorder symptoms

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Dopamine transporter density in patients with attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Diagnostic efficiency of neuropsychological test scores for discriminating boys with and without attention deficit–hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Attention-deficit/hyperactivity disorder endophenotypes

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Effect of nutritional supplements on attentional-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

What is the prevalence of adult ADHD? Results of a population screen of 966 adults

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

A Prospective Four-Year Follow-up Study of Children at Risk for ADHD: Psychiatric, Neuropsychological, and Psychosocial Outcome

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: a drug-placebo response curve analysis

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Molecular genetics of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The Twelfth Jack Tizard Memorial Lecture. The development of offending and antisocial behaviour from childhood: key findings from the Cambridge Study in Delinquent Development.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

A genomewide scan for loci involved in attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Impact of psychostimulants on vesicular monoamine transporter function

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Meta-analysis of intellectual and neuropsychological test performance in attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Genetic influence on parent-reported attention-related problems in a Norwegian general population twin sample.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Symptoms versus impairment: the case for respecting DSM-IV's Criterion D.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Use of Methylphenidate for Attention-Deficit Hyperactivity Disorder in Patients With Epilepsy or Electroencephalographic Abnormalities

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Neuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic review

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Hyperactives as young adults: Past and current substance abuse and antisocial behavior

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Presentation of unrecognized attention deficit hyperactivity disorder in college students

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Genotype influences in vivo dopamine transporter availability in human striatum.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Age-dependent decline of attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The genetic and environmental contributions to attention deficit hyperactivity disorder as measured by the Conners' Rating Scales--Revised.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Gender differences in the effects of oppositional behavior on teacher ratings of ADHD symptoms

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Prediction of Dopamine Transporter Binding Availability by Genotype: A Preliminary Report

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Inattention/hyperactivity and aggression from early childhood to adolescence: heterogeneity of trajectories and differential influence of family environment characteristics

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

A potential natural treatment for attention-deficit/hyperactivity disorder: evidence from a national study

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The impact of reinforcement contingencies on AD/HD: a review and theoretical appraisal

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Temperament and character profiles and the dopamine D4 receptor gene in ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Risperidone in children with autism and serious behavioral problems

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD).

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Validity of self-report and informant rating scales of adult ADHD symptoms in comparison with a semistructured diagnostic interview.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Efficacy of stimulants in adult ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The Use of Antidepressants to Treat Attention Deficit Hyperactivity Disorder in Adults

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Hyperactive boys almost grown up. IV. Criminality and its relationship to psychiatric status.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Adult psychiatric status of hyperactive boys grown up.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Pemoline hepatotoxicity in children

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Methylphenidate effects on symptoms of attention deficit disorder in adults.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

WISC-IV and WISC-III profiles in children with ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Age-dependent expression of attention-deficit/hyperactivity disorder symptoms

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Guidelines for treating depressive illness with antidepressants: A statement from the British Association for Psychopharmacology.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Adult attention deficit hyperactivity disorder and the dopamine D4 receptor gene.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Parents of children with attention-deficit/hyperactivity disorder: psychological and attentional impairment.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: the state of the field and salient challenges for the coming decade

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Prevalence of attention-deficit/hyperactivity disorder symptoms in 4- to 17-year-old children in the general population

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

HYPERACTIVITY IN PRESCHOOL CHILDREN IS HIGHLY HERITABLE

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Unrecognized attention-deficit hyperactivity disorder in adults presenting for outpatient psychotherapy.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Global consensus on ADHD/HKD.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Psychometric and psychopathological characterization of young male prison inmates with and without attention deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Neuropsychological functioning in stimulant-naive boys with hyperkinetic disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Stimulant drugs

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Prediction of antisocial behavior in attention-deficit hyperactivity disorder boys from aggression/defiance scores.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Neuropsychological performance in adult attention-deficit hyperactivity disorder: meta-analysis of empirical data

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Attention deficit hyperactivity disorder: review of ADHD in learning disability: the Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation[DC‐LD] criteria for diagnosis

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Neuropsychological function in adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Structural brain imaging of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Modeling attention-deficit/hyperactivity disorder: a critical appraisal of the cognitive-energetic model

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

A children's global assessment scale (CGAS)

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Clinical guidelines: developing guidelines

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD).

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Psychological heterogeneity in AD/HD--a dual pathway model of behaviour and cognition

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The dual pathway model of AD/HD: an elaboration of neuro-developmental characteristics

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

More to ADHD than meets the eye: observable abnormalities in search behaviour do not account for performance deficits on a discrimination task

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Dopamine transporter genotype and methylphenidate dose response in children with ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Event-related FMRI evidence of frontotemporal involvement in aberrant response inhibition and task switching in attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Hyperactivity and conduct problems as risk factors for adolescent development

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Examining the comorbidity of ADHD-related behaviours and conduct problems using a twin study design

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The genetics of attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

ADHD in adults: a study of clinical characteristics, impairment and comorbidity.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

DSM-IV and ICD-10: a comparison of the correlates of ADHD and hyperkinetic disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

What are the long-term effects of methylphenidate treatment?

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Statistical approaches to complex phenotypes: evaluating neuropsychological endophenotypes for attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Twin study of the etiology of comorbidity between reading disability and attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review

1 reference

https://api.crossref.org/works/10.1177%2F0269881106073219

21 January 2018

Identifiers

10.1177/0269881106073219

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36648476&oldid=1642996204"